Exploring Vestibular Test Battery for Differential Diagnosis of Meniere’s Disease and Vestibular Migraine
Abstract
Introduction: Ménière’s disease (MD) and vestibular migraine (VM) are common causes of recurrent vertigo, often presenting with overlapping symptoms such as episodic vertigo, hearing disturbances, tinnitus, and migraine-associated features. Accurate differentiation between MD and VM remains clinically challenging. This study aims to evaluate the utility of an objective vestibular test battery in distinguishing these conditions. Methods: A prospective cross-sectional study was conducted on 45 ears who were diagnosed as, probable MD (pMD, n = 15), definite MD (dMD, n = 15), and VM ( n = 15). All participants underwent a comprehensive vestibular test battery, including cervical and ocular vestibular evoked myogenic potentials (cVEMPs, oVEMPs), video head impulse test (vHIT), and oculomotor test of video nystagmography (VNG). Results: Vestibular evoked myogenic potentials (VEMPs) showed no significant difference for frequency tuning parameter across three groups of disorders ( P > 0.05) while response rate was significantly lower among patients with dMD followed by VM and pMD for oVEMP test. Parameters of vHIT demonstrated no significant difference across these groups of patients ( P > 0.05) while VNG revealed a significant difference on saccade test among the groups of patients ( P < 0.05), with both saccades and smooth pursuit affected in MD patients, whereas VM primarily exhibited smooth pursuit abnormalities. Conclusion: The study highlights overlapping vestibular test results between MD and VM for VEMP and vHIT while significant difference in test findings were observed for saccade test of VNG.
Fields of Study & Subjects
Vestibular and auditory disorders
Hearing
Cochlea
Tinnitus
Genetics
Tactile and Sensory Interactions
Publication details
- Journal / source
- Indian Journal of Otology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Volume
- 32
- Issue
- 1
- Pages
- 39–44
- Publication date
- 1 January 2026
- Language
- EN